Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Venus Remedies LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:526953NSE Symbol: VENUSREMP/E(TTM):12.98
ISIN Demat:INE411B01019Div & Yield %:0EPS(TTM):34.39
Book Value(Rs):441.0095887Market Cap ( Cr.):596.84Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 575.21537.66576.71514.62320.23301.84
Excise Duty0.000.000.000.000.000.00
Net Sales575.21537.66576.71514.62320.23301.84
Other Income 11.3210.178.4350.3734.934.51
Stock Adjustments 5.00-14.26-3.197.36-6.217.98
Total Income591.53533.57581.95572.35348.95314.33
EXPENDITURE :      
Raw Materials 357.22322.44374.31344.04170.60189.76
Power & Fuel Cost4.994.173.783.393.413.50
Employee Cost 57.5747.6743.7535.8933.7930.26
Other Manufacturing Expenses 10.076.186.474.513.633.90
Selling and Administration Expenses 89.1781.1676.4087.2959.5348.10
Miscellaneous Expenses 0.310.260.009.1740.168.96
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure519.33461.88504.71484.28311.12284.49
Operating Profit72.2171.7077.2588.0737.8429.84
Interest 0.000.000.0012.7313.0525.15
Gross Profit72.2171.7077.2575.3424.794.69
Depreciation25.5531.3732.5834.2831.0532.95
Profit Before Tax46.6640.3344.6741.06-6.26-28.26
Tax12.220.000.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax3.9311.36-4.32-13.211.96-1.15
Reported Net Profit30.5028.9648.9954.27-8.23-27.11
Extraordinary Items 0.370.010.0023.44-6.85-8.96
Adjusted Net Profit30.1328.9548.9930.83-1.38-18.15
Adjst. below Net Profit -0.19-0.460.24-0.10-0.470.07
P & L Balance brought forward164.76136.2687.0232.8541.5568.59
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down195.07164.76136.2687.0232.8541.55
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr22.8221.6736.6543.97-6.67-21.97
Earnings Per Share(Adj)-Unit Curr22.8221.6736.6543.97-6.67-21.97
Book Value-Unit Curr380.48357.63336.21313.10269.21276.25